Education

• MD, Jefferson Medical College, Philadelphia, PA, 1983
• Internship and Residency, Thomas Jefferson University, Philadelphia, PA, 1983-1989
• Fellow, American Heart Association, Thomas Jefferson University, Philadelphia, PA, 1986-1987
• Fellow, Vascular Surgery, University of Missouri-Columbia, Columbia, MO, 1989-1991

Clinical Specialties

Dr. Hoch is certified by the American Board of Surgery, with a certificate of additional qualifications in vascular surgery. He is chief of the vascular surgery service at the William S. Middleton Veterans Administration Hospital. Dr. Hoch has special interests in complex and aortic visceral artery occlusive disease, carotid artery reconstruction, repair of thoracoabdominal aneurysms, use of the minilaparotomy technique to repair aortic aneurysms, and the use of endovascular techniques to repair abdominal aortic aneurysms and manage patients with lower extremity arterial occlusion.

Dr. Hoch provides a wide range of services including Adbominal Aortic Aneurysm (AAA) Repair - Endovascular, Adbominal Aortic Aneurysm (AAA) Repair - Open, Amputation, Angioplasty With Stent Placement, Carotid Endartecotomy, Carotid Stenting, Peripheral Artery Bypass, Thoracic Aortic Aneursym - Endovascular, Thoracic Aortic Aneursym - Open, Thoracic Outlet Syndrome Treatment, and Varicose Vein Treatment.

Research Interests

Dr. Hoch heads the Section of Vascular Surgery’s research laboratory. Research in the lab is focused on the prevention of vein graft intimal hyperplasia, which is the primary clinical cause of aorto-coronary vein graft failures during the first two years after coronary artery bypass surgery.

Dr. Hoch also has clinical research interests in magnetic resonance imaging in vascular patients, thrombolytic therapy, medical management of patients with claudication, and development of the less invasive technique of minilaparotomy for aortic aneurysm repair.

Active Clinical Trials

• A Phase 2, Randomized, Open-label (With Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin (Human) Compared to Plasminogen Activator and Placebo In Patients With Acute Lower Extremity Native Artery or Bypass Graft Occlusion
  Principal Investigator(s): John R Hoch, MD
  Status: Recruiting
  [ClinicalTrials.gov: NCT01222117]
  More Information

Recent Publications

• Invited commentary.
  Hoch JR
  J. Vasc. Surg. 2011 Apr; 53(4):1037-8.
  [PubMed ID: 21439457]
  More Information
• The effect of warfarin therapy on endoleak development after endovascular aneurysm repair (EVAR) of the abdominal aorta.
  Bobadilla JL, Hoch JR, Leverson GE, Tefera G
  J. Vasc. Surg. 2010 Aug; 52(2):267-71.
  [PubMed ID: 20591602]
  More Information
• Effect of early plasma transfusion on mortality in patients with ruptured abdominal aortic aneurysm.
  Mell MW, O'Neil AS, Callcut RA, Acher CW, Hoch JR, Tefera G, Turnipseed WD
  Surgery 2010 Nov; 148(5):955-62.
  [PubMed ID: 20378142]
  More Information
• Impact of intraoperative arteriography on limb salvage for traumatic popliteal artery injury.
  Callcut RA, Acher CW, Hoch J, Tefera G, Turnipseed W, Mell MW
  J Trauma 2009 Aug; 67(2):252-7; discussion 257-8.
  [PubMed ID: 19667876]
  More Information
• Complications of spinal fluid drainage in thoracoabdominal aortic aneurysm repair: a report of 486 patients treated from 1987 to 2008.
  Wynn MM, Mell MW, Tefera G, Hoch JR, Acher CW
  J. Vasc. Surg. 2009 Jan; 49(1):29-34; discussion 34-5.
  [PubMed ID: 18951749]
  More Information